Clinical Trial Update: Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial assessing long-term safety, tolerability, and efficacy of macitentan in Eisenmenger syndrome; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eisenmenger Syndrome
• Pulmonary Arterial Hypertension

Drugs mentioned

• Macitentan (macitentan)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: TERMINATED | Results posted: 2019-04-16